For HCC, it has been reported that mutations in Keap1 or Nrf2 have been detected in approximately 12% of cases [26,27], implying that an active Keap1-Nrf2 pathway could induce or even drive the development of HCC. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.